NeuClone announces Positive Ph I results of Herceptin® (Trastuzumab) Biosimilar

NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality ...

December 13, 2019 | Friday | News
Takeda presents Phase III Trial results in patients with amyloidosis

Japan based Takeda Pharmaceutical Company Limited announced the presentation of the results of tourmaline-AL1 trial in a...

December 9, 2019 | Monday | News
CASI Pharma gets China approval Of CNCT19 Clinical Trial Applications

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therap...

December 4, 2019 | Wednesday | News
Seattle Genetics, Astellas announce Clinical Trial collaboration with Merck

Seattle Genetics, Inc. and Astellas Pharma Inc.have announced a clinical collaboration agreement with Merck, k...

December 3, 2019 | Tuesday | News
Combination of Immunotherapy and VEGF Inhibitor Improves Survival in HCC

Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves over...

November 22, 2019 | Friday | News
Trastuzumab Biosimilar HLX02 Met Primary Endpoint in Breast Cancer

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epi...

November 22, 2019 | Friday | News
CStone announces first patient dosed in the Phase I study of ivosidenib

CStone Pharmaceuticals on 20 Nov 2019 announced that the first patient has been dosed in Phase I bridging the registrati...

November 20, 2019 | Wednesday | News
Roxadustat Phase III study shows positive efficacy in patients with anaemia from CKD

AstraZeneca and FibroGen Inc. (FibroGen) have presented pooled efficacy and cardiovascular (CV) safety analyses from the...

November 11, 2019 | Monday | News
World first clinical trial commences in alcohol use disorder

A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol ...

October 28, 2019 | Monday | News
SCRI honors Clinical Research Coordinators by Distinguished Contributor Award 2019

The Singapore Clinical Research Institute (SCRI), on 22 Oct 2019, announce the nine winners of the inaugural Distinguish...

October 22, 2019 | Tuesday | News
ASLAN enrolls first patient to study ASLAN004 targeting Atopic Dermatitis

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced on 22 Oct 2019, the...

October 22, 2019 | Tuesday | News
Rentschler Biopharma to expand Japanese operation base

Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biop...

October 23, 2019 | Wednesday | News
ImaginAb inks pact with three global pharma companies

ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party coll...

October 15, 2019 | Tuesday | News
Thermo Fisher expands clinical trials capabilities in China

Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials ...

September 26, 2019 | Thursday | News
WCG KMR group invites Biopharma companies to enroll in Clinical Trial Cost Study

The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolme...

September 20, 2019 | Friday | News
Japan's Solasia set to start trials for Darinaparsin

Solasia Pharma KK has  announced that the darinaparsin Phase 2 study patient registration has reached the targ...

September 20, 2019 | Friday | News
ASLAN presents Ph2 study data for Varlitinib tested on BTC patients

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late...

September 19, 2019 | Thursday | News
Covance unveils new R&D center in Shanghai

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, has announced that it...

September 17, 2019 | Tuesday | News